Industry Research Reports

Home > Reports > Chemical & Material > Milbemycin Oxime API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Milbemycin Oxime API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published: 2025-01-07

Pages: 86 Pages

Report ld: 3528007

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Milbemycin Oxime API was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite"s nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Milbemycin Oxime API by region & country, by Type, and by Application.

The Milbemycin Oxime API market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime API.

Market Segmentation

Report Metric
Details
Report Title
Milbemycin Oxime API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global Milbemycin Oxime API Companies Covered
Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd, JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Global Milbemycin Oxime API Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Milbemycin Oxime API Market, Segment by Type
98% Purity

Purity Greater than 98%
Global Milbemycin Oxime API Market, Segment by Application
Dog

Cat

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Milbemycin Oxime API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Milbemycin Oxime API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Milbemycin Oxime API Product Introduction
    1.2 Global Milbemycin Oxime API Market Size Forecast
        1.2.1 Global Milbemycin Oxime API Sales Value (2020-2031)
        1.2.2 Global Milbemycin Oxime API Sales Volume (2020-2031)
        1.2.3 Global Milbemycin Oxime API Sales Price (2020-2031)
    1.3 Milbemycin Oxime API Market Trends & Drivers
        1.3.1 Milbemycin Oxime API Industry Trends
        1.3.2 Milbemycin Oxime API Market Drivers & Opportunity
        1.3.3 Milbemycin Oxime API Market Challenges
        1.3.4 Milbemycin Oxime API Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Milbemycin Oxime API Players Revenue Ranking (2024)
    2.2 Global Milbemycin Oxime API Revenue by Company (2020-2025)
    2.3 Global Milbemycin Oxime API Players Sales Volume Ranking (2024)
    2.4 Global Milbemycin Oxime API Sales Volume by Company Players (2020-2025)
    2.5 Global Milbemycin Oxime API Average Price by Company (2020-2025)
    2.6 Key Manufacturers Milbemycin Oxime API Manufacturing Base and Headquarters
    2.7 Key Manufacturers Milbemycin Oxime API Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Milbemycin Oxime API
    2.9 Milbemycin Oxime API Market Competitive Analysis
        2.9.1 Milbemycin Oxime API Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Milbemycin Oxime API Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2024)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 98% Purity
        3.1.2 Purity Greater than 98%
    3.2 Global Milbemycin Oxime API Sales Value by Type
        3.2.1 Global Milbemycin Oxime API Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Milbemycin Oxime API Sales Value, by Type (2020-2031)
        3.2.3 Global Milbemycin Oxime API Sales Value, by Type (%) (2020-2031)
    3.3 Global Milbemycin Oxime API Sales Volume by Type
        3.3.1 Global Milbemycin Oxime API Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Milbemycin Oxime API Sales Volume, by Type (2020-2031)
        3.3.3 Global Milbemycin Oxime API Sales Volume, by Type (%) (2020-2031)
    3.4 Global Milbemycin Oxime API Average Price by Type (2020-2031)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Dog
        4.1.2 Cat
        4.1.3 Other
    4.2 Global Milbemycin Oxime API Sales Value by Application
        4.2.1 Global Milbemycin Oxime API Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Milbemycin Oxime API Sales Value, by Application (2020-2031)
        4.2.3 Global Milbemycin Oxime API Sales Value, by Application (%) (2020-2031)
    4.3 Global Milbemycin Oxime API Sales Volume by Application
        4.3.1 Global Milbemycin Oxime API Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Milbemycin Oxime API Sales Volume, by Application (2020-2031)
        4.3.3 Global Milbemycin Oxime API Sales Volume, by Application (%) (2020-2031)
    4.4 Global Milbemycin Oxime API Average Price by Application (2020-2031)

 5 Segmentation by Region
    5.1 Global Milbemycin Oxime API Sales Value by Region
        5.1.1 Global Milbemycin Oxime API Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Milbemycin Oxime API Sales Value by Region (2020-2025)
        5.1.3 Global Milbemycin Oxime API Sales Value by Region (2026-2031)
        5.1.4 Global Milbemycin Oxime API Sales Value by Region (%), (2020-2031)
    5.2 Global Milbemycin Oxime API Sales Volume by Region
        5.2.1 Global Milbemycin Oxime API Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Milbemycin Oxime API Sales Volume by Region (2020-2025)
        5.2.3 Global Milbemycin Oxime API Sales Volume by Region (2026-2031)
        5.2.4 Global Milbemycin Oxime API Sales Volume by Region (%), (2020-2031)
    5.3 Global Milbemycin Oxime API Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Milbemycin Oxime API Sales Value, 2020-2031
        5.4.2 North America Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Milbemycin Oxime API Sales Value, 2020-2031
        5.5.2 Europe Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Milbemycin Oxime API Sales Value, 2020-2031
        5.6.2 Asia Pacific Milbemycin Oxime API Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Milbemycin Oxime API Sales Value, 2020-2031
        5.7.2 South America Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Milbemycin Oxime API Sales Value, 2020-2031
        5.8.2 Middle East & Africa Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Milbemycin Oxime API Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Milbemycin Oxime API Sales Value
        6.2.1 Key Countries/Regions Milbemycin Oxime API Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Milbemycin Oxime API Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Milbemycin Oxime API Sales Value, 2020-2031
        6.3.2 United States Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Milbemycin Oxime API Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Milbemycin Oxime API Sales Value, 2020-2031
        6.4.2 Europe Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Milbemycin Oxime API Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Milbemycin Oxime API Sales Value, 2020-2031
        6.5.2 China Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Milbemycin Oxime API Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Milbemycin Oxime API Sales Value, 2020-2031
        6.6.2 Japan Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Milbemycin Oxime API Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Milbemycin Oxime API Sales Value, 2020-2031
        6.7.2 South Korea Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Milbemycin Oxime API Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Milbemycin Oxime API Sales Value, 2020-2031
        6.8.2 Southeast Asia Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Milbemycin Oxime API Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Milbemycin Oxime API Sales Value, 2020-2031
        6.9.2 India Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Milbemycin Oxime API Sales Value by Application, 2024 VS 2031

 7 Company Profiles
    7.1 Livzon Pharmaceutical Group Inc
        7.1.1 Livzon Pharmaceutical Group Inc Company Information
        7.1.2 Livzon Pharmaceutical Group Inc Introduction and Business Overview
        7.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Offerings
        7.1.5 Livzon Pharmaceutical Group Inc Recent Development
    7.2 Zhejiang Hisun Pharmaceutical Co., Ltd
        7.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
        7.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Introduction and Business Overview
        7.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Offerings
        7.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
    7.3 Hubei Honch Pharmaceutical Co.,Ltd
        7.3.1 Hubei Honch Pharmaceutical Co.,Ltd Company Information
        7.3.2 Hubei Honch Pharmaceutical Co.,Ltd Introduction and Business Overview
        7.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Offerings
        7.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Development
    7.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
        7.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
        7.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Introduction and Business Overview
        7.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Offerings
        7.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development

 8 Industry Chain Analysis
    8.1 Milbemycin Oxime API Industrial Chain
    8.2 Milbemycin Oxime API Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Milbemycin Oxime API Sales Model
        8.5.2 Sales Channel
        8.5.3 Milbemycin Oxime API Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Milbemycin Oxime API Market Trends
 Table 2. Milbemycin Oxime API Market Drivers & Opportunity
 Table 3. Milbemycin Oxime API Market Challenges
 Table 4. Milbemycin Oxime API Market Restraints
 Table 5. Global Milbemycin Oxime API Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Milbemycin Oxime API Revenue Market Share by Company (2020-2025)
 Table 7. Global Milbemycin Oxime API Sales Volume by Company (2020-2025) & (KG)
 Table 8. Global Milbemycin Oxime API Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Milbemycin Oxime API Price by Company (2020-2025) & (US$/KG)
 Table 10. Key Manufacturers Milbemycin Oxime API Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Milbemycin Oxime API Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Milbemycin Oxime API
 Table 13. Global Milbemycin Oxime API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Milbemycin Oxime API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Milbemycin Oxime API Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Milbemycin Oxime API Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Milbemycin Oxime API Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Milbemycin Oxime API Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Milbemycin Oxime API Sales Volume by Type: 2020 VS 2024 VS 2031 (KG)
 Table 22. Global Milbemycin Oxime API Sales Volume by Type (2020-2025) & (KG)
 Table 23. Global Milbemycin Oxime API Sales Volume by Type (2026-2031) & (KG)
 Table 24. Global Milbemycin Oxime API Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Milbemycin Oxime API Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Milbemycin Oxime API Price by Type (2020-2025) & (US$/KG)
 Table 27. Global Milbemycin Oxime API Price by Type (2026-2031) & (US$/KG)
 Table 28. Global Milbemycin Oxime API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Milbemycin Oxime API Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Milbemycin Oxime API Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Milbemycin Oxime API Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Milbemycin Oxime API Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Milbemycin Oxime API Sales Volume by Application: 2020 VS 2024 VS 2031 (KG)
 Table 34. Global Milbemycin Oxime API Sales Volume by Application (2020-2025) & (KG)
 Table 35. Global Milbemycin Oxime API Sales Volume by Application (2026-2031) & (KG)
 Table 36. Global Milbemycin Oxime API Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Milbemycin Oxime API Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Milbemycin Oxime API Price by Application (2020-2025) & (US$/KG)
 Table 39. Global Milbemycin Oxime API Price by Application (2026-2031) & (US$/KG)
 Table 40. Global Milbemycin Oxime API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Milbemycin Oxime API Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Milbemycin Oxime API Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Milbemycin Oxime API Sales Value by Region (2020-2025) & (%)
 Table 44. Global Milbemycin Oxime API Sales Value by Region (2026-2031) & (%)
 Table 45. Global Milbemycin Oxime API Sales Volume by Region (KG): 2020 VS 2024 VS 2031
 Table 46. Global Milbemycin Oxime API Sales Volume by Region (2020-2025) & (KG)
 Table 47. Global Milbemycin Oxime API Sales Volume by Region (2026-2031) & (KG)
 Table 48. Global Milbemycin Oxime API Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Milbemycin Oxime API Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Milbemycin Oxime API Average Price by Region (2020-2025) & (US$/KG)
 Table 51. Global Milbemycin Oxime API Average Price by Region (2026-2031) & (US$/KG)
 Table 52. Key Countries/Regions Milbemycin Oxime API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Milbemycin Oxime API Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Milbemycin Oxime API Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Milbemycin Oxime API Sales Volume, (2020-2025) & (KG)
 Table 56. Key Countries/Regions Milbemycin Oxime API Sales Volume, (2026-2031) & (KG)
 Table 57. Livzon Pharmaceutical Group Inc Company Information
 Table 58. Livzon Pharmaceutical Group Inc Introduction and Business Overview
 Table 59. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 60. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Offerings
 Table 61. Livzon Pharmaceutical Group Inc Recent Development
 Table 62. Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
 Table 63. Zhejiang Hisun Pharmaceutical Co., Ltd Introduction and Business Overview
 Table 64. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 65. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Offerings
 Table 66. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
 Table 67. Hubei Honch Pharmaceutical Co.,Ltd Company Information
 Table 68. Hubei Honch Pharmaceutical Co.,Ltd Introduction and Business Overview
 Table 69. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 70. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Offerings
 Table 71. Hubei Honch Pharmaceutical Co.,Ltd Recent Development
 Table 72. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
 Table 73. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Introduction and Business Overview
 Table 74. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 75. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product Offerings
 Table 76. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development
 Table 77. Key Raw Materials Lists
 Table 78. Raw Materials Key Suppliers Lists
 Table 79. Milbemycin Oxime API Downstream Customers
 Table 80. Milbemycin Oxime API Distributors List
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources


List of Figures
 Figure 1. Milbemycin Oxime API Product Picture
 Figure 2. Global Milbemycin Oxime API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Milbemycin Oxime API Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Milbemycin Oxime API Sales Volume (2020-2031) & (KG)
 Figure 5. Global Milbemycin Oxime API Sales Price (2020-2031) & (US$/KG)
 Figure 6. Milbemycin Oxime API Report Years Considered
 Figure 7. Global Milbemycin Oxime API Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Milbemycin Oxime API Players Sales Volume Ranking (2024) & (KG)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Milbemycin Oxime API Revenue in 2024
 Figure 10. Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. 98% Purity Picture
 Figure 12. Purity Greater than 98% Picture
 Figure 13. Global Milbemycin Oxime API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Milbemycin Oxime API Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Milbemycin Oxime API Sales Volume by Type (2020 VS 2024 VS 2031) & (KG)
 Figure 16. Global Milbemycin Oxime API Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Milbemycin Oxime API Price by Type (2020-2031) & (US$/KG)
 Figure 18. Product Picture of Dog
 Figure 19. Product Picture of Cat
 Figure 20. Product Picture of Other
 Figure 21. Global Milbemycin Oxime API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Milbemycin Oxime API Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Milbemycin Oxime API Sales Volume by Application (2020 VS 2024 VS 2031) & (KG)
 Figure 24. Global Milbemycin Oxime API Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Milbemycin Oxime API Price by Application (2020-2031) & (US$/KG)
 Figure 26. North America Milbemycin Oxime API Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Milbemycin Oxime API Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Milbemycin Oxime API Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Milbemycin Oxime API Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Milbemycin Oxime API Sales Volume (%), (2020-2031)
 Figure 38. United States Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Milbemycin Oxime API Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Milbemycin Oxime API Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Milbemycin Oxime API Sales Value by Application (%), 2024 VS 2031
 Figure 59. Milbemycin Oxime API Industrial Chain
 Figure 60. Milbemycin Oxime API Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global market for Milbemycin Oxime API was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite"s nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Milbemycin Oxime API by region & country, by Type, and by Application.

The Milbemycin Oxime API market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime API.

Market Segmentation